ITGB6 and breast carcinoma: The ITGB6 gene, coding for the integrin subunit β6, has been associated with metastasis to distant sites and poor prognosis in breast cancer patients, and targeting avβ6 integrin has been proposed as a novel therapeutic approach for treating high-risk and trastuzumab-resistant breast cancer patients [50].